Skip to main content

Table 3 Reasons for neurologists on how they used the sNfL result in case they perceived it as useful

From: A neurologist’s perspective on serum neurofilament light in the memory clinic: a prospective implementation study

Neurodegenerative diagnosis (n = 20)

No neurodegenerative diagnosis (n = 30)

Other (n = 8)

Confirm AD

N = 10

Exclude neurodegeneration

N = 8

Confirm neurological disorder

N = 3

Confirm neurodegeneration, e.g., MCI, FTD, other

N = 5

Confirm SCD

N = 6

Exclude AD

N = 1

Support AD

N = 2

Confirm no neurodegeneration

N = 4

Exclude neurodegeneration

N = 1

Support neurodegeneration

N = 1

To reassure patient

N = 4

For follow-up

N = 1

Exclude FTD, confirm AD

N = 1

Exclude FTD

N = 2

Due to recent heart attack

N = 1

For follow-up

N = 1

Less support for FTD

N = 1

Other

N = 1

 

Exclude AD

N = 1

 

Exclude CTE

N = 1

Support SCD

N = 1

For patient management

N = 1

Indication for vessel damage

N = 1

  1. “Neurodegeneration” included subjects diagnosed with MCI, AD, or OD; “no neurodegeneration” included subjects with SCD or psychiatric disorder; “other” included subjects with other neurology or a postponed diagnosis. Abbreviations: AD Alzheimer’s disease, MCI mild cognitive impairment